Barclays (LON:BARC) initiated coverage on Natera shares (NASDAQ:NTRA), currently trading at $171.93, with an Overweight rating and a $200 price target. The stock has demonstrated remarkable momentum, ...

Barclays PLC bought a new stake in shares of Genasys Inc. (NASDAQ:GNSS – Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 19,680 shares ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Arm ...

Barclays (LON:BARC) initiated coverage on Exact Sciences (NASDAQ:EXAS), a leading molecular diagnostics company with a market capitalization of $10.14 billion, assigning the stock an Overweight rating ...

Barclays PLC boosted its position in Nayax Ltd. (NASDAQ:NYAX – Free Report) by 5,526.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 2,307 shares of the ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Barclays (LON:BARC) adjusted the firm's stance on Netflix (NASDAQ:NFLX) stock, upgrading it from Underweight to Equalweight ...

Barclays (LON:BARC) began coverage on Guardant Health (NASDAQ:GH) shares, assigning an Overweight rating and setting a price target of $60. The new outlook comes as Guardant Health, a precision ...

We recently compiled a list of the 10 AI News You Probably Missed. In this article, we are going to take a look at where ...

The Nasdaq led gains among Wall Street's main indexes on Wednesday, as investors cheered streaming giant Netflix's strong ...

The S&P500 (SP500) closed in the red on Friday, after the week witnessed new policies from U.S. President Donald Trump, along ...